February 2022 Bio Services News & Insights is now available online. In This Issue: Integrating Microfluidics into Biomanufacturing, Three Reasons to Think Canada When Developing Regenerative Medicine, Microfluidic-Based Assays, and Cell Therapy Applications, Biomanufacturing Trends to Watch in 2022, Developing and Running an Industry-Integrated Human Factors Engineering Course, What Medtech Companies Seek in Acquisition Targets, How to Conduct IEC 60601-1 Instability Testing, Events, Careers, and January Images.
About StarFish Medical
Empowering Medtech Innovation®
StarFish Medical is a full service Medical Device Design company offering design, development, and manufacturing services based in Toronto and Victoria. We use our Pathfinder™ process to reduce wasted effort and increase success for medical device product definition, technical engineering, and product development. Prototype and volume production are delivered within an ISO 13485 certified Quality Management System, manufacturing and clean room facilities. www.starfishmedical.com
StarFish Medical February 2022 News is part of our monthly collection of new insights, tips and news covering medtech and medical device commercialization topics.
StarFish Medical received Canada’s Most Admired Corporate Cultures for 2021 award in the Growth category from Waterstone Human Capital. This national program annually recognizes best-in-class Canadian organizations for having cultures that have helped enhance performance and sustain a competitive advantage.
Scott Phillips, founder and CEO of StarFish Medical, has been architecting the StarFish culture for 22 years. “The core of our HR philosophy is to enable employees to do the best work of their lives in the service of client success. Our guiding principles help us make the right decisions as we seek the right wise tradeoffs to achieve those aims.” We’re hiring! Check out our Careers Page for current opportunities.
StarFish Medical media contact:
Notes to editors